| 3/17/2024 | 30045099 | Clinical research drug Dato-DXd (DS-1062a)(100mg/vial) (Datopotamab Deruxtecan 20mg/ml) Lot No: 30350.355/1. Expiry date: January 31, 2026. Manufacturer Baxter Oncology GmbH. New 100% | XXXXXXXXXX | 60 | UNA | 5295.048 | Germany | NA |
| 3/17/2024 | 30045099 | Clinical research drug Dato-DXd (DS-1062a)(100mg/vial) (Datopotamab Deruxtecan 20mg/ml) Lot No: 30350.355/1. Expiry date: January 31, 2026. Manufacturer Baxter Oncology GmbH. New 100% | XXXXXXXXXX | 85 | UNA | 7501.318 | Germany | NA |
| 3/10/2024 | 30045099 | Clinical research drug Dato-DXd (DS-1062a)(100mg/vial) (DatopotamabDeruxtecan 20mg/ml) Lot No: 30350.355/1. Expiry date: January 31, 2026. Manufacturer Baxter Oncology GmbH. New 100% | XXXXXXXXXX | 54 | UNA | 4775.274 | Germany | NA |
| 3/10/2024 | 30045099 | Clinical research drug Dato-DXd (DS-1062a)(100mg/vial) (DatopotamabDeruxtecan 20mg/ml) Lot No: 30350.355/1. Expiry date: January 31, 2026. Manufacturer Baxter Oncology GmbH. New 100% | XXXXXXXXXX | 68 | UNA | 6013.308 | Germany | NA |
| 3/3/2024 | 30045099 | Clinical research drug Dato-DXd (DS-1062a)(100mg/vial) (DatopotamabDeruxtecan 20mg/ml) Lot No: 30350.264/1. Expiry date: May 31, 2024. Manufacturer Baxter Oncology GmbH. New 100% | XXXXXXXXXX | 8 | UNA | 709.1864 | Germany | NA |
| 2/17/2024 | 30045099 | Clinical research drug Dato-DXd (DS-1062a)(100mg/vial) (DatopotamabDeruxtecan) Lot No: 30350.536/1. Expiry date: January 31, 2026. Manufacturer Baxter Oncology GmbH. New 100% | XXXXXXXXXX | 11 | UNA | 982.7785 | Germany | NA |
| 2/17/2024 | 30045099 | Clinical research drug Dato-DXd (DS-1062a)(100mg/vial) (DatopotamabDeruxtecan) Lot No: 30350.536/1. Expiry date: January 31, 2026. Manufacturer Baxter Oncology GmbH. New 100% | XXXXXXXXXX | 2 | UNA | 178.687 | Germany | NA |
| 2/17/2024 | 30045099 | Clinical research drug Dato-DXd (DS-1062a)(100mg/vial) (DatopotamabDeruxtecan) Lot No: 30350.355/1. Expiry date: January 31, 2026. Manufacturer Baxter Oncology GmbH. New 100% | XXXXXXXXXX | 10 | UNA | 893.435 | Germany | NA |
| 1/30/2024 | 30045099 | Clinical research drug Dato-DXd (DS-1062a)(100mg/vial) (DatopotamabDeruxtecan) Lot No: 30350.536/1. Expiry date: January 31, 2026. Manufacturer Baxter Oncology GmbH. New 100% | XXXXXXXXXX | 10 | Bottle/Bottle/Tube | 887.7555 | Germany | NA |
| 1/28/2024 | 30045099 | Clinical research drug Dato-DXd (DS-1062a)(100mg/vial) (DatopotamabDeruxtecan) Lot No: 30350.536/1. Expiry date: January 31, 2026. Manufacturer Baxter Oncology GmbH. New 100% | XXXXXXXXXX | 9 | Bottle/Bottle/Tube | 798.97995 | Germany | NA |